Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Ibrutinib Combined with Rituximab in Treatment-Naive Patients with Follicular Lymphoma: Arm 1+Arm 2 Results from a Multicenter, Open-Label Phase 2 Study Fowler, N., Nastoupil, L., de Vos, S., Knapp, M., Flinn, I. W., Chen, R. W., Advani, R. H., Bhatia, S., Martin, P., Mena, R., Suzuki, S., Beaupre, D. M., Neuenburg, J. K., Palomba, M. AMER SOC HEMATOLOGY. 2016
View details for Web of Science ID 000394452307142